Investigator-Initiated Studies Main Article

Investigator-Initiated Studies

Daiichi Sankyo is committed to supporting research to address unmet medical needs of patients around the world.

Daiichi Sankyo offers the opportunity for external researchers who are interested in conducting their own research related to Daiichi Sankyo therapeutic areas of interest to submit an independent research concept that is subsequently reviewed by an internal review committee. Daiichi Sankyo may provide funding and other forms of support, such as clinical trial material, to support studies initiated and sponsored by external researchers.

If you would like to read about our current therapeutic areas of focus click Product Pipeline. If you are interested in submitting a concept, or have a question, please review  the Investigator-Initiated Study (IIS) Reference Guide and submit your concept to

If you are interested in submitting a concept related to  trastuzumab deruxtecan (fam-trastuzumab deruxtecan-nxki in the United States only), please contact prior to making your submission and note the following:

  •  Concepts will be prioritized accordingly based on scientific merit and fit with the clinical program.


PP-US-ON-1095 07/20

Non-Continuing Medical Education Grants Main Article More Stories

More Stories

Daiichi Sankyo Cancer Enterprise

Daiichi Sankyo is focused on aligning rigorous science with unique patients' needs to accelerate the development of innovative therapies for cancer.

read more ...